Endocare signs Asian cryoablation deals:
This article was originally published in Clinica
Endocare has formed exclusive distribution agreements with Ensafe Industrial for Taiwan, and Inchcape Healthcare for Singapore, for Endocare's targeted cryoablation technology for liver cancer. Endocare, of Irvine, California, says the two companies will sell and service its technology in countries where the per capita incidence of liver cancer is significantly higher than the global average. Endocare is negotiating similar distribution agreements for China and Japan.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.